(Q53261303)

12 May 2018

title

Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. (English)

1 reference

12 May 2018

0 references

1 reference

hepatocellular carcinoma

1 reference

Takeshi Nishida

1

1 reference

12 May 2018

Koichi Tsuneyama

2

1 reference

12 May 2018

Makoto Fujimoto

3

1 reference

12 May 2018

Kazuhiro Nomoto

4

1 reference

12 May 2018

Shinichi Hayashi

5

1 reference

12 May 2018

Shigeharu Miwa

6

1 reference

12 May 2018

Takahiko Nakajima

7

1 reference

12 May 2018

Yuko Nakanishi

8

1 reference

12 May 2018

Yoshiyuki Sasaki

9

1 reference

12 May 2018

Wataru Suzuki

10

1 reference

12 May 2018

Seiichi Iizuka

11

1 reference

12 May 2018

Mitsunobu Nagata

12

1 reference

12 May 2018

Tsutomu Shimada

13

1 reference

12 May 2018

Masaki Aburada

14

1 reference

12 May 2018

Yutaka Shimada

15

1 reference

12 May 2018

Johji Imura

16

1 reference

12 May 2018

publication date

19 November 2012

1 reference

12 May 2018

published in

Laboratory Investigation

1 reference

12 May 2018

volume

93

1 reference

12 May 2018

issue

2

1 reference

12 May 2018

page(s)

230-241

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2012.155

exact match

0 references

cites work

Epidemiology and natural history of NAFLD and NASH.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Nonalcoholic fatty liver disease: a review of current understanding and future impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Nonalcoholic steatohepatitis: definition and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Non-alcoholic steatohepatitis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Steatohepatitis induced by intragastric overfeeding in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: a role for IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Clinicopathological features of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

The effect of lifestyle changes in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Current therapeutic strategies in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Thiazolidinediones and the liver in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Pioglitazone: side effect and safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Analysis of the role of hepatic PPARγ expression during mouse liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Preventive effects of Bofutsushosan on obesity and various metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

Insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

A new mouse model of spontaneous diabetes derived from ddY strain

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

Flavangenol (pine bark extract) and its major component procyanidin B1 enhance fatty acid oxidation in fat-loaded models

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

Genetic analysis of obese diabetes in the TSOD mouse

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

Two cases from the spectrum of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2012.155

7 January 2021

10.1038/LABINVEST.2012.155

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

23212097

1 reference

12 May 2018